Vericel Corp

VCELNasdaqCIK 887359HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 343 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Vericel Corp, Reports and events
Filed	Form	What it is	Accession number
2022-11-0908:52 ET	10-Q	Quarterly reportPeriod 2022-09-30	0001628280-22-029082
2022-11-0908:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-22-029065
2022-08-0309:04 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001628280-22-020355
2022-08-0308:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-22-020345
2022-08-0216:05 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001104659-22-085173
2022-05-0408:51 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001628280-22-012151
2022-05-0408:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-22-012148
2022-04-2916:37 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001104659-22-053666
2022-03-1708:26 ET	DEF 14A	Proxy statementPeriod 2022-04-27	0001206774-22-000743
2022-02-2417:17 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001104659-22-026723
2022-02-2409:03 ET	10-K	Annual reportPeriod 2021-12-31	0001628280-22-003661
2022-02-2408:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-22-003659
2022-02-0216:06 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001104659-22-010829
2022-01-1207:25 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-22-003394
2021-11-0909:14 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001628280-21-022419
2021-11-0908:23 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-022408
2021-08-2717:11 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001104659-21-110616
2021-08-0416:08 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001628280-21-015540
2021-08-0408:07 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-015447
2021-06-2916:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-086855
2021-06-2116:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001104659-21-083495
2021-06-0208:40 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001104659-21-075418
2021-05-0508:06 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001628280-21-008983
2021-05-0507:14 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-008966
2021-04-2916:52 ET	8-K	5.07 Shareholder vote results	0001104659-21-057713
2021-03-1908:00 ET	DEF 14A	Proxy statementPeriod 2021-04-28	0001206774-21-000753
2021-02-2416:48 ET	10-K	Annual reportPeriod 2020-12-31	0001628280-21-003081
2021-02-2408:42 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-002956
2021-02-1208:56 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-021303
2021-01-2508:35 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001104659-21-006897
2021-01-1107:30 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-21-002701
2020-11-0515:11 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001628280-20-015697
2020-11-0509:27 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-015603
2020-10-1408:00 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-114711
2020-09-1616:05 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-105660
2020-09-0816:04 ET	8-K	5.02 Departure or appointment of officers or directors	0001104659-20-103049
2020-08-0513:46 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001628280-20-011753
2020-08-0508:45 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-011708
2020-07-0916:12 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-082371
2020-06-3016:08 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-078966
2020-05-1116:36 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001628280-20-007473
2020-05-0508:19 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-006360
2020-05-0116:10 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001104659-20-055469
2020-04-0209:02 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-042219
2020-03-2016:10 ET	DEF 14A	Proxy statementPeriod 2020-04-29	0001047469-20-001647
2020-02-2517:23 ET	10-K	Annual reportPeriod 2019-12-31	0001628280-20-002229
2020-02-2508:39 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-002155
2019-11-0515:22 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001628280-19-013312
2019-11-0508:19 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-19-013240
2019-08-0613:58 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001628280-19-010077

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:53 ET. Listed shows no prices and gives no investment advice.